Clinical Trials Directory

Trials / Unknown

UnknownNCT02844283

Ad-HGF Treatment for Myocardial Infarction

Adenovirus Carrying Hepatocyte Growth Factor (Ad-HGF) Treatment for Myocardial Infarction

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
The First Affiliated Hospital with Nanjing Medical University · Academic / Other
Sex
All
Age
30 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This will be the first clinical trial use Ad-HGF gene for the treatment of myocardial infarction disease.

Conditions

Interventions

TypeNameDescription
DRUGAd-HGF
OTHER0.9% NaCl

Timeline

Start date
2016-11-01
Primary completion
2018-07-01
First posted
2016-07-26
Last updated
2016-07-26

Source: ClinicalTrials.gov record NCT02844283. Inclusion in this directory is not an endorsement.

Ad-HGF Treatment for Myocardial Infarction (NCT02844283) · Clinical Trials Directory